SEATTLE, April 17, 2018 -- Trupanion, Inc. (Nasdaq:TRUP), a leading provider of medical insurance for cats and dogs, announced today it will report financial results for its 2018 first quarter after the market closes on Tuesday, May 1, 2018. The company will host a conference call that day beginning shortly after 1:30 p.m. PT / 4:30 p.m. ET.
A live webcast will be available on Trupanion's Investor Relations site under Investor Events at http://investors.trupanion.com and will be archived online for 3 months upon completion of the conference call.
Participants can access the conference call by dialing 1-877-407-0784 (United States) or 1-201-689-8560 (International). A telephonic replay of the call will also be available after the completion of the call, by dialing 1-844-512-2921 (United States) or 1-412-317-6671 (International) and entering the replay pin number: 13678512.
About Trupanion:
Trupanion is a leader in medical insurance for cats and dogs throughout the United States and Canada. For almost two decades, Trupanion has given pet owners peace of mind so they can focus on their pet's recovery, not financial stress. Trupanion is committed to providing pet owners with the highest value in pet medical insurance. Trupanion is listed on NASDAQ under the symbol "TRUP". The company was founded in 2000 and is headquartered in Seattle, WA. Trupanion policies are issued, in the United States, by its wholly-owned insurance entity American Pet Insurance Company and, in Canada, by Omega General Insurance Company. For more information, please visit Trupanion.com.
Contacts:
Investors:
Laura Bainbridge, Addo Investor Relations
310.829.5400
[email protected]
Media:
Scott Janzen, Trupanion Director of Communications
888.612.1138 ext 3450
[email protected]


AbbVie Sues HHS Over Medicare Price Controls on Botox Under Inflation Reduction Act
U.S. Commerce Department Reaches $252 Million Settlement With Applied Materials Over China Exports
Xiaomi EV Deliveries Surpass 600,000 Units as SU7 and YU7 Drive Strong Growth
Novocure Stock Surges 30% After FDA Approves Optune Pax for Pancreatic Cancer Treatment
Sachem Head Boosts Warner Bros. Discovery Stake Amid Netflix Deal and Paramount Bid
Paramount Skydance Appoints Rene Augustine as SVP of Global Public Policy Amid Warner Bros Takeover Battle
How Marco Pharma International Preserves German Homeopathic Traditions in America
Spirit Airlines Seeks Court Approval to Auction 20 Airbus A320/A321 Aircraft Amid Bankruptcy
ByteDance Advances AI Chip Development With Samsung Manufacturing Talks
Bank of America CEO Brian Moynihan’s 2025 Compensation Rises 17% to $41 Million Amid Strong Profit Growth
Michael Kors Marks 45 Years at New York Fashion Week with Fall/Winter Collection Showcase
Anduril Eyes $60 Billion Valuation in New Funding Round to Expand Defense Manufacturing and Autonomous Fighter Jet Development
GE Aerospace Expands Singapore Engine Repair Hub with Automation and AI to Tackle Aviation Bottlenecks
Novartis’ Vanrafia Shows Strong Phase 3 Results in IgA Nephropathy, Paving Way for Full Approval
Lockheed Martin Secures $101M in U.S. Defense Contracts for AEGIS, F-35, and Missile Systems
FTC Questions Apple News Over Alleged Bias Against Conservative Media
Grok AI Market Share Surges as xAI Faces Scrutiny Over Image Generation Controversy 



